BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 28139496)

  • 1. Therapeutic efficacy of an elemental diet for patients with crohn's disease and its association with amino acid metabolism.
    Nakano M; Tominaga K; Hoshino A; Sugaya T; Kanke K; Hiraishi H
    Saudi J Gastroenterol; 2017; 23(1):20-27. PubMed ID: 28139496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymeric versus elemental diet as primary treatment in active Crohn's disease: a randomized, double-blind trial.
    Verma S; Brown S; Kirkwood B; Giaffer MH
    Am J Gastroenterol; 2000 Mar; 95(3):735-9. PubMed ID: 10710067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term efficacy of enteral nutrition in the treatment of active Crohn's disease: a randomized, controlled trial comparing nutrient formulas.
    Sakurai T; Matsui T; Yao T; Takagi Y; Hirai F; Aoyagi K; Okada M
    JPEN J Parenter Enteral Nutr; 2002; 26(2):98-103. PubMed ID: 11871742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapeutic effects of combined enteral nutrition with Tripterygium Wilfordii poly-glycoside in remission induction of active adult Crohn's disease].
    Gong JF; Niu LY; Wei XW; Zhu WM; Li N; Li JS
    Zhonghua Wai Ke Za Zhi; 2009 Aug; 47(16):1213-7. PubMed ID: 19781164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of nutritional therapy for perforating and non-perforating Crohn's disease.
    Ikeuchi H; Yamamura T; Nakano H; Kosaka T; Shimoyama T; Fukuda Y
    Hepatogastroenterology; 2004; 51(58):1050-2. PubMed ID: 15239244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized controlled study comparing elemental diet and steroid treatment in Crohn's disease.
    Zoli G; Carè M; Parazza M; Spanò C; Biagi PL; Bernardi M; Gasbarrini G
    Aliment Pharmacol Ther; 1997 Aug; 11(4):735-40. PubMed ID: 9305483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surrogate markers and clinical indices, alone or combined, as indicators for endoscopic remission in anti-TNF-treated luminal Crohn's disease.
    af Björkesten CG; Nieminen U; Turunen U; Arkkila P; Sipponen T; Färkkilä M
    Scand J Gastroenterol; 2012 May; 47(5):528-37. PubMed ID: 22356594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initial response and subsequent course of Crohn's disease treated with elemental diet or prednisolone.
    Gorard DA; Hunt JB; Payne-James JJ; Palmer KR; Rees RG; Clark ML; Farthing MJ; Misiewicz JJ; Silk DB
    Gut; 1993 Sep; 34(9):1198-202. PubMed ID: 8406153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of enteral nutrition on energy metabolism in patients with Crohn's disease.
    Zhao J; Dong JN; Gong JF; Wang HG; Li Y; Zhang L; Zuo LG; Feng Y; Gu LL; Li N; Li JS; Zhu WM
    World J Gastroenterol; 2015 Jan; 21(4):1299-304. PubMed ID: 25632205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in nutritional status and disease activity during treatment of Crohn's disease with elemental diet.
    Teahon K; Pearson M; Smith T; Bjarnason I
    Scand J Gastroenterol; 1995 Jan; 30(1):54-60. PubMed ID: 7701251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phase 2 study of allogeneic mesenchymal stromal cells for luminal Crohn's disease refractory to biologic therapy.
    Forbes GM; Sturm MJ; Leong RW; Sparrow MP; Segarajasingam D; Cummins AG; Phillips M; Herrmann RP
    Clin Gastroenterol Hepatol; 2014 Jan; 12(1):64-71. PubMed ID: 23872668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Remission maintained by monotherapy after biological + immunosuppressive combination for Crohn's disease in clinical practice.
    Ampuero J; Rojas-Feria M; Castro-Fernández M; Millán-Lorenzo M; Guerrero-Jiménez P; Romero-Gómez M
    J Gastroenterol Hepatol; 2016 Jan; 31(1):112-8. PubMed ID: 26173493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Remission following an elemental diet or prednisolone in Crohn's disease.
    Papadopoulou A; Rawashdeh MO; Brown GA; McNeish AS; Booth IW
    Acta Paediatr; 1995 Jan; 84(1):79-83. PubMed ID: 7734907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nutritional therapy versus 6-mercaptopurine as maintenance therapy in patients with Crohn's disease.
    Hanai H; Iida T; Takeuchi K; Arai H; Arai O; Abe J; Tanaka T; Maruyama Y; Ikeya K; Sugimoto K; Nakamura T; Nakamura K; Watanabe F
    Dig Liver Dis; 2012 Aug; 44(8):649-54. PubMed ID: 22542605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement of fecal calprotectin improves monitoring and detection of recurrence of Crohn's disease after surgery.
    Wright EK; Kamm MA; De Cruz P; Hamilton AL; Ritchie KJ; Krejany EO; Leach S; Gorelik A; Liew D; Prideaux L; Lawrance IC; Andrews JM; Bampton PA; Jakobovits SL; Florin TH; Gibson PR; Debinski H; Macrae FA; Samuel D; Kronborg I; Radford-Smith G; Selby W; Johnston MJ; Woods R; Elliott PR; Bell SJ; Brown SJ; Connell WR; Day AS; Desmond PV; Gearry RB
    Gastroenterology; 2015 May; 148(5):938-947.e1. PubMed ID: 25620670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adherence to an elemental diet for preventing postoperative recurrence of Crohn's disease.
    Ohara N; Mizushima T; Iijima H; Takahashi H; Hiyama S; Haraguchi N; Inoue T; Nishimura J; Shinzaki S; Hata T; Matsuda C; Yamamoto H; Doki Y; Mori M
    Surg Today; 2017 Dec; 47(12):1519-1525. PubMed ID: 28534264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD4+ immune response as a potential biomarker of patient reported inflammatory bowel disease (IBD) activity.
    Brandhorst G; Weigand S; Eberle C; Raddatz D; Karaus M; Oellerich M; Walson PD
    Clin Chim Acta; 2013 Jun; 421():31-3. PubMed ID: 23485644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum calprotectin as a biomarker for Crohn's disease.
    Meuwis MA; Vernier-Massouille G; Grimaud JC; Bouhnik Y; Laharie D; Piver E; Seidel L; Colombel JF; Louis E;
    J Crohns Colitis; 2013 Dec; 7(12):e678-83. PubMed ID: 23845231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and Nutritional Impact of a Semi-Elemental Hydrolyzed Whey Protein Diet in Patients with Active Crohn's Disease: A Prospective Observational Study.
    Ferreiro B; Llopis-Salinero S; Lardies B; Granados-Colomina C; Milà-Villarroel R
    Nutrients; 2021 Oct; 13(10):. PubMed ID: 34684624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pharmacokinetic effect of adalimumab on thiopurine metabolism in Crohn's disease patients.
    Wong DR; Pierik M; Seinen ML; van Bodegraven AA; Gilissen LP; Bus P; Bakker JA; Masclee AA; Neef C; Engels LG; Hooymans PM
    J Crohns Colitis; 2014 Feb; 8(2):120-8. PubMed ID: 23932783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.